Consonance Capital Management as of March 31, 2017
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 24 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 9.6 | $92M | 6.2M | 14.78 | |
| United Therapeutics Corporation (UTHR) | 9.1 | $87M | 642k | 135.38 | |
| Globus Med Inc cl a (GMED) | 9.1 | $87M | 2.9M | 29.62 | |
| Clovis Oncology | 8.9 | $85M | 1.3M | 63.67 | |
| Amarin Corporation (AMRN) | 8.4 | $80M | 25M | 3.20 | |
| Mallinckrodt Pub | 7.3 | $70M | 1.6M | 44.57 | |
| Myriad Genetics (MYGN) | 6.0 | $57M | 3.0M | 19.20 | |
| Corcept Therapeutics Incorporated (CORT) | 5.9 | $57M | 5.2M | 10.96 | |
| AtriCure (ATRC) | 5.8 | $55M | 2.9M | 19.15 | |
| Advanced Accelerat spon ads each rep 2 ord | 5.5 | $52M | 1.3M | 39.86 | |
| Pacira Pharmaceuticals (PCRX) | 4.7 | $44M | 973k | 45.60 | |
| La Jolla Pharmaceuticl Com Par | 4.4 | $42M | 1.4M | 29.85 | |
| Retrophin | 4.1 | $39M | 2.1M | 18.46 | |
| Novadaq Technologies | 2.5 | $24M | 3.0M | 7.79 | |
| Corindus Vascular Robotics I | 2.1 | $20M | 15M | 1.31 | |
| Acadia Healthcare (ACHC) | 1.4 | $14M | 311k | 43.60 | |
| Acorda Therapeutics | 1.4 | $13M | 619k | 21.00 | |
| Array BioPharma | 1.3 | $12M | 1.4M | 8.94 | |
| Vericel (VCEL) | 0.9 | $8.4M | 3.0M | 2.80 | |
| Biosante Pharmaceuticals (ANIP) | 0.7 | $7.1M | 143k | 49.51 | |
| Adma Biologics (ADMA) | 0.7 | $6.2M | 1.3M | 4.88 | |
| Biolase Technology | 0.2 | $1.7M | 1.3M | 1.35 | |
| Seaspine Holdings | 0.1 | $692k | 88k | 7.85 | |
| Strongbridge Bioph shs usd | 0.0 | $48k | 10k | 4.80 |
